Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Marchetti

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Blood Transfusion = Trasfusione Del Sangue|April 5, 2021
Increased platelet thrombus formation under flow conditions in whole blood from polycythaemia vera patientsAlfonso Vignoli, Sara Gamba, Paola E J van der Meijden, et al.
American Journal of Hematology|May 1, 2020
Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional studyFrancesca Schieppati, Laura Russo, Marina Marchetti, et al.
Frontiers in Oncology|November 10, 2018
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein InteractionLaura Caleca, Irene Catucci, Gisella Figlioli, et al.
American Journal of Hematology|March 29, 2011
Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia veraMarina Panova-Noeva, Marina Marchetti, Henri Maria Spronk, et al.
Frontiers in Cardiovascular Medicine|June 27, 2022
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 PatientsMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
Blood Advances|June 11, 2024
Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasmsSarah Kelliher, Sara Gamba, Luisa Weiss, et al.
British Journal of Haematology|February 2, 2026
Venous thromboembolism in patients with multiple myeloma treated with B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy: A systematic reviewPedro Henrique Fernandes do Carmo Las Casas, Javier Marco-Ayala, Elmina-Eleftheria Lefkou, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasmsSarah Kelliher, Sara Gamba, Luisa Weiss, et al.
Science Translational Medicine|June 17, 2026
Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activationDimitra Karagkouni, Marisa A Brake, Rushad Patell, et al.
Cancers|August 28, 2025
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During ChemotherapyMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Blood Transfusion = Trasfusione Del Sangue|April 5, 2021
Increased platelet thrombus formation under flow conditions in whole blood from polycythaemia vera patientsAlfonso Vignoli, Sara Gamba, Paola E J van der Meijden, et al.
American Journal of Hematology|May 1, 2020
Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional studyFrancesca Schieppati, Laura Russo, Marina Marchetti, et al.
Frontiers in Oncology|November 10, 2018
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein InteractionLaura Caleca, Irene Catucci, Gisella Figlioli, et al.
American Journal of Hematology|March 29, 2011
Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia veraMarina Panova-Noeva, Marina Marchetti, Henri Maria Spronk, et al.
Frontiers in Cardiovascular Medicine|June 27, 2022
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 PatientsMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
Blood Advances|June 11, 2024
Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasmsSarah Kelliher, Sara Gamba, Luisa Weiss, et al.
British Journal of Haematology|February 2, 2026
Venous thromboembolism in patients with multiple myeloma treated with B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy: A systematic reviewPedro Henrique Fernandes do Carmo Las Casas, Javier Marco-Ayala, Elmina-Eleftheria Lefkou, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasmsSarah Kelliher, Sara Gamba, Luisa Weiss, et al.
Science Translational Medicine|June 17, 2026
Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activationDimitra Karagkouni, Marisa A Brake, Rushad Patell, et al.
Cancers|August 28, 2025
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During ChemotherapyMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
Pageof 9